English

GSK Valaciclovir for the Suppression and Episodic Treatment of Genital HSV Infection in HIV-Infected Persons Month 6 End of Study CENTRAL LABORATORY BLOOD NCT00079911

1 forms  
Study administration
Description

Study administration

Subject Identifier
Description

Subject Identifier

Data type

integer

Alias
UMLS CUI [1]
C2348585
Visit Date
Description

Visit Date

Data type

date

Measurement units
  • DD/MMM/YY
Alias
UMLS CUI [1]
C1320303
DD/MMM/YY
CENTRAL LABORATORY BLOOD
Description

CENTRAL LABORATORY BLOOD

Date sample taken
Description

Date sample taken

Data type

date

Alias
UMLS CUI [1]
C1302413
PREGNANCY TEST PROMPT
Description

PREGNANCY TEST PROMPT

HIV RNA PROMPT
Description

HIV RNA PROMPT

HIV-ASSOCIATED CONDITIONS
Description

HIV-ASSOCIATED CONDITIONS

CONCOMITANT MEDICATIONS
Description

CONCOMITANT MEDICATIONS

ADVERSE EVENTS
Description

ADVERSE EVENTS

Back to the top of the page

Similar models

GSK Valaciclovir for the Suppression and Episodic Treatment of Genital HSV Infection in HIV-Infected Persons Month 6 End of Study CENTRAL LABORATORY BLOOD NCT00079911

1 forms
Name
Type
Description | Question | Decode (Coded Value)
Data type
Alias
Item Group
Study administration
Subject Identifier
Item
Subject Identifier
integer
C2348585 (UMLS CUI [1])
Visit Date
Item
Visit Date
date
C1320303 (UMLS CUI [1])
Item Group
CENTRAL LABORATORY BLOOD
Date sample taken
Item
Date sample taken
date
C1302413 (UMLS CUI [1])
Item Group
PREGNANCY TEST PROMPT
Item Group
HIV RNA PROMPT
Item Group
HIV-ASSOCIATED CONDITIONS
Item Group
CONCOMITANT MEDICATIONS
Item Group
ADVERSE EVENTS
Back to the top of the page